Related Experiment Video
Updated: Aug 17, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Methadone-induced Torsade de pointes tachycardias
Christian Sticherling1, Beat A Schaer, Peter Ammann
1University Hospital Basel, Div. of Cardiology, Basel, Switzerland. csticherling@uhbs.ch
Abstract:
Methadone is a synthetic opioid frequently used in drug maintenance programs for heroin addicts. It prolongs the QT-interval and is mainly metabolized by the isoenzyme CYP3A4 of the hepatic cytochrome-P450-system, which is used by numerous other QT-prolonging agents. Its most severe side effect is the development of life-threatening Torsade de pointes ventricular tachycardia in the setting of a prolonged QT-interval. Since drug addicts are prone to concomitant medical conditions requiring additional medication as well as to continued abuse of cocaine, they are at higher risk for developing this major complication of methadone therapy. Before subjecting patients on methadone to other drugs, the QT-interval should be determined and it should be ascertained whether the new agent has the property to prolong the QT-interval or is metabolised by the cytochrome-P450 system.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Desensitization and Tachyphylaxis
Several...
Dysrhythmias II: Classification of Tachyarrhythmias
Heart Failure Drugs: Inotropic Agents
Toxidromes: Clinical Features
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

